Salim Syed
Stock Analyst at Mizuho
(0)
# 4360
Out of 5,354 analysts
80
Total ratings
38.60%
Success rate
-10.22%
Average return
Main Sectors:
Top Industries:
| Name | Action | PT | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
CYTK Cytokinetics | Maintains: Outperform | 103 84 | 32.29 | 160.14% | 7 | May 29, 2025 | |
BIIB Biogen | Maintains: Outperform | 207 169 | 132.09 | 27.94% | 16 | May 7, 2025 | |
AMGN Amgen | Maintains: Neutral | 235 280 | 288.71 | -3.02% | 8 | May 7, 2025 | |
GILD Gilead Sciences | Maintains: Outperform | 100 117 | 109.45 | 6.9% | 7 | May 5, 2025 | |
WVE WAVE Life Sciences | Maintains: Outperform | 19 22 | 6.64 | 231.33% | 5 | Nov 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 20 16 | 1.81 | 783.98% | 7 | Nov 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 113 163 | 34.49 | 372.6% | 3 | Sep 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Outperform | 25 18 | 8.45 | 113.02% | 4 | Aug 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 34 | 21.84 | 55.68% | 1 | Apr 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 82 99 | 38.03 | 160.32% | 3 | Mar 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 60 53 | 37.72 | 40.51% | 7 | Mar 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 12 6 | 0.72 | 733.33% | 6 | Mar 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 28 21 | 0.79 | 2558.23% | 5 | Nov 16, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 168 36 | 16 | 125% | 1 | Nov 16, 2022 |